inhaler
Lupin Healthcare launches Beclu carbon neutral inhalers for asthma treatment
June 22, 2023Research and Development Asthma & COPD, Beclu, Lupin Healthcare, asthma, carbon neutral, inhaler
UK-based subsidiary of Lupin Limited, Lupin Healthcare, has announced the UK launch of its carbon neutral pressurised metered dose inhalers …
FDA approves GlaxoSmithKline’s Trelegy for treating asthma
September 10, 2020Research and Development Ashtma, inhaler
The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …
US approves new generic to treat people suffering from respiratory conditions
August 25, 2020Manufacturing and Production asthma, inhaler
The FDA has granted Lupin Ltd approval for their generic version of ProAir, which is used to prevent asthma symptoms …
AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD
August 23, 2018Research and Development AstraZeneca, COPD, GSK, anoro, inhaler, pharma
Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted …
Vectura asthma treatment fails at Phase III
August 30, 2016Manufacturing and Production, Research and Development asthma, inhaler, phase III, phase III failure, vectura
Respiratory drug specialist Vectura’s asthma treatment Flutiform was unsuccessful in meeting the primary endpoint in its Phase III trial conducted …
Boehringer spends €100 million on inhaler
September 30, 2014Manufacturing and Production, Sales and Marketing Boehringer, Germany, Spiriva, Striverdi, inhaler, olodaterol, respimat
Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
